| Reaction Details |
|---|
 | Report a problem with these data |
| Target | Serine/threonine-protein kinase 4 |
|---|
| Ligand | BDBM50583980 |
|---|
| Substrate/Competitor | n/a |
|---|
| Meas. Tech. | ChEMBL_2158669 (CHEMBL5043419) |
|---|
| IC50 | 80±n/a nM |
|---|
| Citation |  Bata, N; Chaikuad, A; Bakas, NA; Limpert, AS; Lambert, LJ; Sheffler, DJ; Berger, LM; Liu, G; Yuan, C; Wang, L; Peng, Y; Dong, J; Celeridad, M; Layng, F; Knapp, S; Cosford, NDP Inhibitors of the Hippo Pathway Kinases STK3/MST2 and STK4/MST1 Have Utility for the Treatment of Acute Myeloid Leukemia. J Med Chem65:1352-1369 (2022) [PubMed] Article |
|---|
| More Info.: | Get all data from this article, Assay Method |
|---|
| |
| Serine/threonine-protein kinase 4 |
|---|
| Name: | Serine/threonine-protein kinase 4 |
|---|
| Synonyms: | KRS2 | MST1 | STK4 | STK4_HUMAN | Serine/threonine-protein kinase 3/4 | Serine/threonine-protein kinase 4 (STK4) | Serine/threonine-protein kinase MST1 |
|---|
| Type: | Enzyme |
|---|
| Mol. Mass.: | 55611.40 |
|---|
| Organism: | Homo sapiens (Human) |
|---|
| Description: | Q13043 |
|---|
| Residue: | 487 |
|---|
| Sequence: | METVQLRNPPRRQLKKLDEDSLTKQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQ
VPVESDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKT
LTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAK
RNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNP
PPTFRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQHPFVRSAKGVSILRDLINEAMDV
KLKRQESQQREVDQDDEENSEEDEMDSGTMVRAVGDEMGTVRVASTMTDGANTMIEHDDT
LPSQLGTMVINAEDEEEEGTMKRRDETMQPAKPSFLEYFEQKEKENQINSFGKSVPGPLK
NSSDWKIPQDGDYEFLKSWTVEDLQKRLLALDPMMEQEIEEIRQKYQSKRQPILDAIEAK
KRRQQNF
|
|
|
|---|
| BDBM50583980 |
|---|
| n/a |
|---|
| Name | BDBM50583980 |
|---|
| Synonyms: | CHEMBL5089132 |
|---|
| Type | Small organic molecule |
|---|
| Emp. Form. | C17H17ClN4O |
|---|
| Mol. Mass. | 328.796 |
|---|
| SMILES | OC1CCN(CC1)c1ncnc2[nH]cc(-c3cccc(Cl)c3)c12 |
|---|
| Structure | 
|
|---|
Search and Browse
